A Drug-Drug Interaction Study of MK 8527 With a Combined Oral Contraceptive (LNG/EE)

Clinical trial NCT06783192 · COMPLETED

Trial details

NCT number: NCT06783192
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Human Immunodeficiency Virus (HIV)HIV Pre-Exposure Prophylaxis

Start date: 2023-08-14
Primary completion: 2023-10-11
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.